1. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
- Author
-
Hum, Ryan Malcolm, Lilleker, James B, Lamb, Janine A, Oldroyd, Alexander G S, Wang, Guochun, Wedderburn, Lucy R, Diederichsen, Louise P, Schmidt, Jens, Danieli, Maria Giovanna, Oakley, Paula, Griger, Zoltan, Phuong, Thuy Nguyen Thi, Kodishala, Chanakya, Mercado, Monica Vazquez-Del, Andersson, Helena, Paepe, Boel De, Bleecker, Jan L De, Maurer, Britta, McCann, Liza, and Pipitone, Nicolo
- Subjects
DERMATOMYOSITIS ,DIFFERENTIAL diagnosis ,RESEARCH funding ,RAYNAUD'S disease ,SKIN diseases ,MYOSITIS ,EXFOLIATIVE dermatitis ,AUTOANTIBODIES ,EXANTHEMA ,INTERSTITIAL lung diseases ,ANTISYNTHETASE syndrome ,ARTHRITIS ,COMPARATIVE studies ,TUMORS ,DISEASE complications ,SYMPTOMS ,ADULTS - Abstract
Objectives To compare clinical characteristics, including the frequency of cutaneous, extramuscular manifestations and malignancy, between adults with anti-synthetase syndrome (ASyS) and DM. Methods Using data regarding adults from the MYONET registry, a cohort of DM patients with anti-Mi2/-TIF1γ/-NXP2/-SAE/-MDA5 autoantibodies, and a cohort of ASyS patients with anti-tRNA synthetase autoantibodies (anti-Jo1/-PL7/-PL12/-OJ/-EJ/-Zo/-KS) were identified. Patients with DM sine dermatitis or with discordant dual autoantibody specificities were excluded. Sub-cohorts of patients with ASyS with or without skin involvement were defined based on presence of DM-type rashes (heliotrope rash, Gottron's papules/sign, violaceous rash, shawl sign, V-sign, erythroderma, and/or periorbital rash). Results In total 1054 patients were included (DM, n = 405; ASyS, n = 649). In the ASyS cohort, 31% (n = 203) had DM-type skin involvement (ASyS-DMskin). A higher frequency of extramuscular manifestations, including Mechanic's hands, Raynaud's phenomenon, arthritis, interstitial lung disease and cardiac involvement differentiated ASyS-DMskin from DM (all P < 0.001), whereas higher frequency of any of four DM-type rashes—heliotrope rash (n = 248, 61% vs n = 90, 44%), violaceous rash (n = 166, 41% vs n = 57, 9%), V-sign (n = 124, 31% vs n = 28, 4%), and shawl sign (n = 133, 33% vs n = 18, 3%)—differentiated DM from ASyS-DMskin (all P < 0.005). Cancer-associated myositis (CAM) was more frequent in DM (n = 67, 17%) compared with ASyS (n = 21, 3%) and ASyS-DMskin (n = 7, 3%) cohorts (both P < 0.001). Conclusion DM-type rashes are frequent in patients with ASyS; however, distinct clinical manifestations differentiate these patients from classical DM. Skin involvement in ASyS does not necessitate increased malignancy surveillance. These findings will inform future ASyS classification criteria and patient management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF